Solutions & Services
Therapeutic expertise
Why APICES
We want to share the acknowledgment that APICES has received in BLARWE study, which is a bladder cancer retrospective study, published in the ASCO GU 2025 congress, in which APICES has collaborated in start-up, project management, monitoring, biostatistics, and medical writing activities.
This means a great motivation to all the APICES team to give continuity to the implication we have in every project in which we collaborate. APICES is very proud of the recognition of our work, and we would like to thank AstraZeneca, and Dr. Javier Puente for giving us the opportunity to appear in the acknowledgments of the publication and congratulate them and all the investigators for their project success.
This retrospective study aims to provide a comprehensive description of the epidemiology of bladder cancer in Spain, and to generate robust evidence on the clinical characteristics, treatment patterns, and clinical outcomes of these patients in routine clinical practice.
You can find further information in the following link: Real-world epidemiology and clinical outcomes of bladder cancer patients in Spain: BLARWE multicenter study. | Journal of Clinical Oncology
Get the latest clinical insights delivered to your feed or inbox!
On integration, change leadership, and strengthening Apices as one unified organization In a clinical research environment where sponsors value stability, predictability, and quality above all else, organizational change must be approached with care. As APICES...
RWE and HEOR have moved from supporting inputs to decision-critical evidence across development and access. This article summarises what teams are using them for today, how evidence generation is changing, and where AI adds value when paired with the right governance.
Stage III NSCLC care sits at the intersection of multimodal treatment and real-world constraints. The GEOCP-SEOR population-based study describes how patients are managed across Spain, and APICES was acknowledged for supporting the publication through medical editorial assistance.